Search results
Jump to navigation
Jump to search
- ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2011.<ref>{{FDA-Drug_Details|201699}}</ref>2 KB (243 words) - 13:18, 2 February 2023
- "In conventional medicine (see [[New Drug Application]]), the basic phases of evaluating a drug determine: if it causes dangerous2 KB (277 words) - 10:04, 28 November 2010
- {{r|New drug application}}4 KB (505 words) - 16:36, 11 January 2010
- ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2008.<ref>{{FDA-Drug_Details|065379}}</ref>6 KB (836 words) - 14:09, 2 February 2023
- ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2009.<ref>{{FDA-Drug_Details|078560}}</ref>6 KB (751 words) - 13:17, 2 February 2023
- ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 2002.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda/4 KB (501 words) - 13:18, 2 February 2023
- ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) in 1993.<ref>{{FDA-Drug_Details|020151}}</ref> A generic version wa3 KB (390 words) - 14:34, 2 February 2023
- ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2003.<ref>[http://www.accessdata.fda.gov/scripts/cder/drugsatfda7 KB (844 words) - 13:17, 2 February 2023
- === Abbreviated New Drug Application === ...ications/AbbreviatedNewDrugApplicationANDAGenerics/default.htm Abbreviated New Drug Application] (or "ANDA") with the [[Food and Drug Administration]] (FDA) and seeks to d18 KB (2,553 words) - 13:17, 2 February 2023
- ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) on July 29, 1999.<ref>{{FDA-Drug_Details|040353}}</ref>9 KB (1,159 words) - 14:09, 2 February 2023
- ...approves drugs only for the ''indications'' that are spelled out in the [[New Drug Application]] process. With some narrow exceptions, however, it is within the discretio9 KB (1,390 words) - 17:46, 28 December 2008
- ...pprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/ Abbreviated New Drug Application] (ANDA) in 2009.<ref>{{FDA-Drug_Details|078560}}</ref>20 KB (2,588 words) - 04:36, 22 November 2023
- ...ability and bioavailablility, and suggested packaging and labeling, as a [[new drug application]] (NDA) to the FDA. The NDA is then reviewed by teams of FDA employees, inc ...per study and testing. The drug industry must pay "user fees" with every [[new drug application]]. A drug is given "fast-track" status if it meets a medical need not curre40 KB (5,751 words) - 04:07, 19 September 2013
- ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) by the FDA in 1987.<ref>[http://www.accessdata.fda.gov/scripts/cder/20 KB (2,873 words) - 11:51, 2 February 2023
- ...owDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/ New Drug Application] (NDA) by the FDA in 1987.<ref>[http://www.accessdata.fda.gov/scripts/cder/31 KB (4,264 words) - 13:22, 2 February 2023
- Trials of potential treatments, for ethical reasons, tend to involve [[New Drug Application|multiple stages]], starting with small safety tests of the drug or other th ...onsent]] for participation in a trial. In the United States, there is an [[New drug application| approval procedure]] for clinical trials in human subjects, whether for re79 KB (10,925 words) - 14:12, 2 February 2023
- ...cy authorization for the use of intravenous peramavir, which had been in [[New Drug Application|Phase III clinical trials]]. <ref name=FDA-EUA-par>{{citation37 KB (5,103 words) - 13:22, 2 February 2023
- Trials of potential treatments, for ethical reasons, tend to involve [[New Drug Application|multiple stages]], starting with small safety tests of the drug or other th ...onsent]] for participation in a trial. In the United States, there is an [[New drug application| approval procedure]] for clinical trials in human subjects, whether for re87 KB (12,105 words) - 14:08, 2 February 2023
- ...nd related regulatory organizations passed Good Manufacturing Processes, [[New Drug Application]] clinical trials, and the rest, homeopathy always managed to be grandfathe ...this valid material for the article? Should there be a stronger link to [[New Drug Application]] with compare-and-contrast?[[User:Howard C. Berkowitz|Howard C. Berkowitz]100 KB (15,913 words) - 10:45, 7 March 2024
- ...ugs. The Manufacturers of homeopathic drugs are deferred from submitting [[new drug application]]s to FDA. Their products are exempt from good manufacturing practice requi ...as a compendium of drugs. In contrast, non-homeopathic drugs for which a [[New Drug Application]] is required must be accompanied by approved evidence of safety and effica94 KB (13,911 words) - 12:14, 13 March 2024